PAPI, ALESSIO
 Distribuzione geografica
Continente #
NA - Nord America 4.406
AS - Asia 3.185
EU - Europa 3.113
AF - Africa 272
SA - Sud America 202
Continente sconosciuto - Info sul continente non disponibili 161
OC - Oceania 6
Totale 11.345
Nazione #
US - Stati Uniti d'America 4.333
VN - Vietnam 967
SG - Singapore 795
CN - Cina 770
IT - Italia 733
GB - Regno Unito 642
DE - Germania 330
SE - Svezia 291
UA - Ucraina 200
HK - Hong Kong 197
FR - Francia 194
IN - India 142
BR - Brasile 130
RU - Federazione Russa 130
CH - Svizzera 122
NL - Olanda 118
IE - Irlanda 104
TG - Togo 100
CI - Costa d'Avorio 72
ZA - Sudafrica 59
FI - Finlandia 57
JP - Giappone 52
EE - Estonia 46
CA - Canada 44
BD - Bangladesh 36
BG - Bulgaria 34
JO - Giordania 31
PH - Filippine 25
TH - Thailandia 25
PL - Polonia 24
BE - Belgio 23
AR - Argentina 22
KR - Corea 21
ID - Indonesia 20
SC - Seychelles 17
TW - Taiwan 16
EC - Ecuador 15
IQ - Iraq 14
IR - Iran 14
SA - Arabia Saudita 13
CL - Cile 12
NG - Nigeria 12
GR - Grecia 11
ES - Italia 10
HR - Croazia 10
CO - Colombia 9
PK - Pakistan 9
RO - Romania 8
TR - Turchia 8
EG - Egitto 7
AT - Austria 6
AU - Australia 6
MX - Messico 6
UZ - Uzbekistan 6
CR - Costa Rica 5
HU - Ungheria 5
MY - Malesia 5
PE - Perù 5
LB - Libano 4
PR - Porto Rico 4
CZ - Repubblica Ceca 3
LT - Lituania 3
NO - Norvegia 3
PT - Portogallo 3
PY - Paraguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BS - Bahamas 2
GY - Guiana 2
IL - Israele 2
JM - Giamaica 2
KZ - Kazakistan 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
SI - Slovenia 2
VE - Venezuela 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GP - Guadalupe 1
GT - Guatemala 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MA - Marocco 1
MM - Myanmar 1
MN - Mongolia 1
MQ - Martinica 1
MU - Mauritius 1
PS - Palestinian Territory 1
SX - ???statistics.table.value.countryCode.SX??? 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VG - Isole Vergini Britanniche 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.188
Città #
Singapore 544
Southend 540
Ashburn 446
Chandler 363
Fairfield 304
San Jose 260
Dong Ket 234
Santa Clara 221
Hong Kong 182
Hanoi 169
Wilmington 164
Ho Chi Minh City 149
Houston 147
Woodbridge 145
Council Bluffs 138
Jacksonville 136
Ann Arbor 134
Princeton 133
Bologna 128
Beijing 114
Bern 114
Cambridge 112
Seattle 112
Dublin 102
Lomé 100
Boardman 84
Abidjan 72
Rome 65
Lauterbourg 60
Westminster 59
Padova 56
Helsinki 54
Nanjing 51
Hefei 48
Los Angeles 48
New York 48
Dallas 46
Buffalo 43
Tokyo 42
Milan 39
Berlin 38
Haiphong 38
Sofia 34
Amman 31
Turin 31
Da Nang 30
Changsha 29
Dearborn 29
Guangzhou 28
São Paulo 27
Frankfurt am Main 26
Jinan 24
Medford 24
Shenyang 24
Saint Petersburg 23
Brussels 22
Mülheim 22
Florence 20
Shanghai 20
Hebei 19
Chicago 18
Nanchang 18
San Diego 17
Zhengzhou 17
Jiaxing 16
Munich 15
Redmond 15
The Dalles 15
Verona 15
Phoenix 14
Redwood City 14
Tianjin 14
Falkenstein 13
Hangzhou 13
Toronto 13
Yubileyny 13
Abeokuta 12
Johannesburg 12
Mahé 12
Brooklyn 11
Mountain View 11
Warsaw 11
Des Moines 10
Düsseldorf 10
Fremont 10
Naples 10
Olalla 10
Redondo Beach 10
Seoul 10
Amsterdam 9
Ardabil 9
Bangkok 9
Quận Ba 9
San Francisco 9
Wuhan 9
Atlanta 8
Fuzhou 8
Jakarta 8
Kunming 8
Montreal 8
Totale 7.018
Nome #
Effetti co-cancerogeni della vitamina E a livello prostatico 518
Co-carcinogenic effects of vitamin E in prostate 300
Epigallocatechin-3-gallate and 6-OH-11-O-hydroxyphenanthrene limit BE(2)-C neuroblastoma cell growth and neurosphere formation in vitro 268
Co-mutagenic and pro-oxidant effects of Vitamin E promotes DNA damage and cell transformation in prostate 264
Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study. 257
Antiprotease strategy in combination with gemcitabine as a putative novel therapeutic approach for pancreatic cancer treatment 256
Betalains increase vitexin-2-O-xyloside cytotoxicity in CaCo-2 cancer cells 256
EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion 239
Kaiware Daikon (Raphanus sativus, L.) Extract: a Naturally Multipotent Chemopreventive Agent 232
Genomic stability, anti-inflammatory phenotype, and up-regulation of the RNAseH2 in cells from centenarians 232
Carbonic anhydrase 9 mRNA/microRNA34a interplay in hypoxic human mammospheres 230
A Ligand of Retinoid X Receptor Overcome Multidrug Resistance in Human Colon Carcinoma LoVomdr Cell Line 226
Peroxisome Proliferator Activated Receptor-α/Hypoxia Inducible Factor-1α Interplay Sustains Carbonic Anhydrase IX and Apoliprotein E Expression in Breast Cancer Stem Cells 224
Cytotoxic and Antioxidant Activity of 4-Methylthio-3-butenyl Isothiocyanate from Raphanus sativus L. (Kaiware Daikon) Sprouts 214
A RXR ligand 6-OH-11-O-hydroxyphenanthrene with antitumour properties enhances (-)-epigallocatechin-3-gallate activity in three human breast carcinoma cell lines. 212
Cell growth inhibition and apoptotic effect of the rexinoid 6-OH-11-O-hydroxyphenantrene on human osteosarcoma and mesenchymal stem cells. 211
RXRgamma and PPARgamma ligands in combination to inhibit proliferation and invasiveness in colon cancer cells 209
PPARγ and RXR Ligands Disrupt the Inflammatory Cross-talk in the Hypoxic Breast Cancer Stem Cells Niche. 203
Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon 202
Antitumoral effect of retinoids and ciglitazone on the melanoma cell line G361: key role of peroxisome proliferator activated receptor-gamma 199
Slug/β-Catenin–Dependent Proinflammatory Phenotype in Hypoxic Breast Cancer Stem Cells 197
(-)-epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line 194
Doxorubicin and cisplatin induce apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue 194
Epigallocatechin-3-gallate Increases RXRγ-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines 191
ANTITUMORAL EFFECT OF RETINOIDS: A COMPARISON BETWEEN ALL TRANS RETINOIC ACID AND IIF, A SPECIFIC LIGAND OF RXR 188
Nuclear receptors agonists exert opposing effects on the inflammation-dependent survival of breast cancer stem cells. 188
ANTITUMORAL EFFICACY OF RETINOIDS ON HUMAN MULTIDRUG RESISTANT COLON CARCINOMA (LOVO MDR) AND LEUKEMIA (HL60- MDR) CELL LINES 187
Antitumoral effect of retinoids on two human bladder cancer cell lines 182
6-OH-11-hydroxyphenantrene and PPARgamma ligands in combination to inhibit proliferation and invasiveness in colon cancer cells 175
Antitumoral effect of retinoids and ciglitazone on the melanoma cell line G361: key role of peroxisome proliferator-activated receptor gamma 172
Antitumoral efficacy of retinoids on human multidrug resistance colon carcinoma (LoVoMDR) and leukemia (HL-60 MDR) cell lines 168
Tumor invasiveness in the fibrosarcoma cell line HT-1080: effect of retinoids 167
Search for multidrug resistance modulators: effects of retinoids in human colon carcinoma cells 165
Antitumoral effect of retinoids on two human bladder cancer cell lines 164
Epigenetic Modifiers as Anticancer Drugs: Effectiveness of Valproic Acid in Neural Crest-derived Tumor Cells 163
Enhanced effects of PPARγ ligands and RXR selective retinoids in combination to inhibit migration and invasiveness in cancer cells. 163
Inhibitory effects of retinoic acid and IIF on growth, migration and invasiveness in U87MG human glioblastoma cell line, 160
Is somatostatin a physiological regulator of human trophoblast functions? 158
Polymeric Micelles Using Pseudo-Amphiphilic Block Copolymers 158
Cytotoxic and antioxidant activity of freeze-dried extract from Japanese daikon sprout (Raphanus sativus, L) 157
Retinoid Receptor Ligands are Potent Anti-inflammatory Agents in Breast Cancer Stem Cells Model 156
Vitexin-2-O-xyloside, raphasatin and (-)-epigallocatechin-3-gallate synergistically affect cell growth and apoptosis of colon cancer cells 152
Epigallocatechin-3-gallate inhibits doxorubicin-induced inflammation on human ovarian tissue 152
Polymeric micelles using pseudo-amphiphilic block copolymers and their cellular uptake 151
Role of nuclear receptors in breast cancer stem cells 151
PPAR-alpha nuclear receptor/ApoE axis: a new target of Breast Cancer Stem Cells 150
Growth Inhibition and Proapoptotic Activity Induction by IIF and Valproic Acid on RA-resistant Leukemia Cells. 150
Anti-invasive Effects and Proapoptotic Activity Induction by the Rexinoid IIF and Valproic Acid in Combination on Colon Cancer Cell Lines. 148
EFFECTS OF RETINOIDS ON DRUG SENSITIVE AND MULTIDRUG RESISTANT HUMAN COLON CARCINOMA CELLS 145
PPARγ and retinoid X receptor ligands are potent antitumoral agents in the glioblastoma cell line U87MG 144
Growth inhibition and proapototic activity induction by the retinoid IIF and valproic acid on HT-29 colon cancer cell line 144
Inhibitory effect of the retinoid IIF on cancer cell invasion mediated by the down regulation of matrix metalloproteinases expression in human glioblastoma cells 139
Trattamento di cellule MCF-7 resistenti al tamoxifene con (-)-epigallocatechina-3-gallato 137
Dynamin controls extracellular level of Awd/Nme1 metastasis suppressor protein 125
PPARgamma and RXRligans act sinergistically as potent antineoplastic agents in vitro and in vivo glioma models 123
Tumor invasiveness in the fibrosarcoma cell line HT-1080: effect of retinoids 122
The rexinoid 6-OH-11-O-hydroxyphenantrene induces apoptosis of human osteosarcoma and mesenchymal stem cells. 119
(-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells. 119
Retinoids Hamper Inflammation in Normal and Cancer Epithelial Cell Lines. 115
null 91
XXI Convegno Annuale ABCD (Stress cellulare: sopravvivenza ed apoptosi), Atti convegno 90
null 79
Totale 11.345
Categoria #
all - tutte 28.847
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.847


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.020 0 0 56 80 84 62 25 82 28 115 251 237
2022/20231.575 137 246 85 179 87 112 31 81 279 45 122 171
2023/2024435 22 60 19 51 37 90 32 36 7 32 31 18
2024/20251.441 67 202 135 122 287 83 71 40 7 130 14 283
2025/20263.126 250 181 230 174 401 177 271 140 792 240 106 164
2026/2027507 113 94 300 0 0 0 0 0 0 0 0 0
Totale 11.345